Isofurans, but not F2‐isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease
Authors:
- L. Jackson RobertsLRL. Jackson Roberts
- Jing ZhangJZJing Zhang
Open Access
- 4 April 2003
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 85 (3) , 645-650
Abstract
F2‐isoprostanes (F2‐IsoPs) are well‐established sensitive and specific markers of oxidative stressin vivo. Isofurans (IsoFs) are also products of lipid peroxidation, but in contrast to F2‐IsoPs, their formation is favored when oxygen tension is increasedin vitroorin vivo. Mitochondrial dysfunction in Parkinson's disease (PD) may not only lead to oxidative damage to brain tissue but also potentially result in increased intracellular oxygen tension, thereby influencing relative concentrations of F2‐IsoPs and IsoFs. In this study, we attempted to compare the levels of F2‐IsoPs and IsoFs esterified in phospholipids in the substantia nigra (SN) from patients with PD to those of age‐matched controls as well as patients with other neurodegenerative diseases, including dementia with Lewy body disease (DLB), multiple system atrophy (MSA), and Alzheimer's disease (AD). The results demonstrated that IsoFs but not F2‐IsoPs in the SN of patients with PD and DLB were significantly higher than those of controls. Levels of IsoFs and F2‐IsoPs in the SN of patients with MSA and AD were indistinguishable from those of age‐matched controls. This preferential increase in IsoFs in the SN of patients with PD or DLB not only indicates a unique mode of oxidant injury in these two diseases but also suggests different underlying mechanisms of dopaminergic neurodegeneration in PD and DLB from those of MSA.Keywords
This publication has 34 references indexed in Scilit:
- Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patientsAmyotrophic Lateral Sclerosis, 2002
- Brain Regional Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer’s DiseaseThe American Journal of Pathology, 2001
- THE ISOPROSTANES: UNIQUE PROSTAGLANDIN-LIKE PRODUCTS OF FREE-RADICAL-INITIATED LIPID PEROXIDATION*Drug Metabolism Reviews, 1999
- Secondary Excitotoxicity Contributes to Dopamine-Induced Apoptosis of Dopaminergic Neuronal CulturesBiochemical and Biophysical Research Communications, 1998
- Neurotoxicity of Endogenous CysteinylcatecholsExperimental Neurology, 1997
- Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's DiseaseJournal of Neurochemistry, 1997
- Mitochondrial respiratory chain function in multiple system atrophyMovement Disorders, 1997
- Mitochondria, free radicals, and neurodegenerationCurrent Opinion in Neurobiology, 1996
- Fibroblasts That Express Aromatic Amino Acid Decarboxylase Have Increased Sensitivity to the Synergistic Cytotoxicity of L-Dopa and ManganeseToxicology and Applied Pharmacology, 1994
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983